Results 41 to 50 of about 456,012 (313)
Pediatric Blood &Cancer, EarlyView.ABSTRACT Background While Wilms tumor (WT) typically has a favorable prognosis, relapsed cases—especially those with high‐risk histology—remain therapeutically challenging after intensive frontline therapy. The combination of vincristine and irinotecan has demonstrated activity in pediatric solid tumors, and pazopanib, a multi‐targeted tyrosine kinase ...
Maria Debora De Pasquale +6 more
wiley +1 more source
Numerical Range on Weighted Hardy Spaces as Semi Inner Product Spaces
Analele Stiintifice ale Universitatii Ovidius Constanta: Seria Matematica, 2017 The semi-inner product, in the sense of Lumer, on weighted Hardy space which generate the norm is unique. Also we will discuss some properties of the numerical range of bounded linear operators on weighted Hardy spaces.
Heydari Mohammad Taghi
doaj +1 more source
Pediatric Blood &Cancer, EarlyView.ABSTRACT We sought to identify potential early risk biomarkers for lung disease in children post‐allogeneic HCT. Patients with pulmonary function tests 3 months post‐transplant and plasma samples between days 7 and 14 post‐HCT were included. Six of 27 subjects enrolled had reduced forced expiratory volume 1 (FEV1) z scores.
Isabella S. Small +3 more
wiley +1 more source
Pediatric Blood &Cancer, EarlyView.ABSTRACT The pediatric hematology‐oncology fellowship training curriculum has not substantially changed since its inception. The first year of training is clinically focused, and the second and third years are devoted to scholarship. However, this current structure leaves many fellows less competitive in the current job market, resulting in ...
Scott C. Borinstein +3 more
wiley +1 more source
NUMERICAL RANGE AND PONCELET PROPERTY
Taiwanese Journal of Mathematics, 2003 This expository article gives an account of the recent developments on the Poncelet property for numerical ranges of the compressions of the shift~\(S(\phi)\). It can be considered as an updated and more advanced edition of the recent expository article published by \textit{P. Y. Wei} [Am. Math. Mon. 107, No. 6, 528--540 (2000; Zbl 0985.51016)].
Gau, Hwa-Long, Wu, Pei Yuan
openaire +2 more sources
Psychosocial Outcomes in Patients With Endocrine Tumor Syndromes: A Systematic Review
Pediatric Blood &Cancer, EarlyView.ABSTRACT Introduction The combination of disease manifestations, the familial burden, and varying penetrance of endocrine tumor syndromes (ETSs) is unique. This review aimed to portray and summarize available data on psychosocial outcomes in patients with ETSs and explore gaps and opportunities for future research and care.
Daniël Zwerus +6 more
wiley +1 more source
Journal of Mathematical Analysis and Applications, 2003 Let \({\mathfrak a}\) be a complex Banach algebra with unit \(e\). The algebraic numerical range \(V(a)\) of an element \(a\) in \({\mathfrak a}\) is the set \(\{f(a): f\) is a bounded linear functional on \({\mathfrak a}\) such that \(f(e)= \| f\|=1\}\).
Li, Chi-Kwong +2 more
openaire +2 more sources
Pediatric Blood &Cancer, EarlyView.ABSTRACT Purpose Metabolic syndrome (MetS) is a common complication in survivors of childhood acute lymphoblastic and myeloid leukemia (AL), and a major risk factor for premature cardiovascular disease, type‐2‐diabetes, and metabolic dysfunction‐associated steatotic liver disease (MASLD).
Visentin Sandrine +10 more
wiley +1 more source
Pediatric Blood &Cancer, EarlyView.ABSTRACT Background The Improving Population Outcomes for Renal Tumours of childhood (IMPORT) is a prospective clinical observational study capturing detailed demographic and outcome data on children and young people diagnosed with renal tumours in the United Kingdom and the Republic of Ireland.
Naomi Ssenyonga +56 more
wiley +1 more source
Pediatric Blood &Cancer, EarlyView.ABSTRACT Introduction We developed MedSupport, a multilevel medication adherence intervention designed to address root barriers to medication adherence. This study sought to explore the feasibility and acceptability of the MedSupport intervention strategies to support a future full‐scale randomized controlled trial.
Elizabeth G. Bouchard +8 more
wiley +1 more source